Natural History of Minimally Classic Subfoveal Choroidal Neovascular Lesions in the Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Investigation: Outcomes Potentially Relevant to Management - TAP Report No. 6

Archives of Ophthalmology

Volumn 122, Issue 3, 2004, Pages 325-329

  Bressler, Susan B ^a   Pieramici, Dante J ^a   Koester, John M ^b   Bressler, Neil M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Norvatis AG   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOPORPHYRIN DERIVATIVE; PLACEBO;

CLASSIC SUBFOVEAL CHOROIDAL NEOVASCULAR LESION; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; OPTIC DISK; PATIENT MONITORING; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; SUBRETINAL NEOVASCULARIZATION; TREATMENT INDICATION; VISUAL ACUITY;

CHOROIDAL NEOVASCULARIZATION; FLUORESCEIN ANGIOGRAPHY; FOVEA CENTRALIS; HUMANS; MACULAR DEGENERATION; MONITORING, PHYSIOLOGIC; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; RANDOMIZED CONTROLLED TRIALS; VISUAL ACUITY;

EID: 1542288088     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.122.3.325     Document Type: Review

References (9)

1. Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials - TAP Report 1. Arch Ophthalmol. 1999;117:1329-1345.
2. Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials - TAP Report 2. Arch Ophthalmol. 2001; 119:198-207.
3. Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes - TAP Report No. 3. Arch Ophthalmol. 2002;120:1443-1454.
4. Verteporfin in Photodynamic Therapy Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization - Verteporfin in Photodynamic Therapy Report 2. Am J Ophthalmol 2001;131:541-560.
5. Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) and Verteporfin in Photodynamic Therapy (VIP) Study Groups. Effect of baseline lesion size, visual acuity, and lesion composition on visual acuity change from baseline with and without verteporfin therapy in choroidal neovascularization secondary to age-related macular degeneration - TAP and VIP Report No. 1. Am J Ophthalmol. 2003;136:407-418.
6. Bressler NM, Rosenfeld PJ, Lim JI, VIM Study Group. A phase II placebo-controlled, double-masked randomized trial: Verteporfin in Minimally Classic CNV due to AMD (VIM) [abstract]. In: 2003 Annual Meeting Abstract and Program Planner of the Association for Research in Vision and Ophthalmology; May 5, 2003; Fort Lauderdale, Fla. Abstract 1100. Available at: http://www.arvo.org. Accessed May 22, 2003.
7. Verteporfin Roundtable 2000 and 2001 Participants, Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) Study Group Principal Investigators, Verteporfin in Photodynamic Therapy (VIP) Study Group Principal Investigators. Guidelines for using verteporfin (Visudyne®) in photodynamic therapy to treat choroidal neovascularization due to age-related macular degeneration and other causes. Retina. 2002;22:6-18.
8. Macular Photocoagulation Study Group. Subfoveal neovascular lesions in age-related macular degeneration: guidelines for evaluation and treatment in the Macular Photocoagulation Study. Arch Ophthalmol. 1991;109:1242-1257.
9. Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) and Verteporfin in Photodynamic Therapy (VIP) Study Groups. Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin: fluorescein angiographic guidelines for evaluation and treatment - TAP and VIP Report No. 2. Arch Ophthalmol. 2003;121:1253-1268.